Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19

Little empirical data support the use of telemedicine to provide medical and developmental follow-up care to preterm and high-risk infants after hospital discharge. Nevertheless, the COVID-19 pandemic temporarily rendered telemedicine the only means by which to provide essential follow-up care to th...

Descripción completa

Detalles Bibliográficos
Autores principales: DeMauro, Sara B., Duncan, Andrea F., Hurt, Hallam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022519/
https://www.ncbi.nlm.nih.gov/pubmed/33892961
http://dx.doi.org/10.1016/j.semperi.2021.151430
_version_ 1783674946081259520
author DeMauro, Sara B.
Duncan, Andrea F.
Hurt, Hallam
author_facet DeMauro, Sara B.
Duncan, Andrea F.
Hurt, Hallam
author_sort DeMauro, Sara B.
collection PubMed
description Little empirical data support the use of telemedicine to provide medical and developmental follow-up care to preterm and high-risk infants after hospital discharge. Nevertheless, the COVID-19 pandemic temporarily rendered telemedicine the only means by which to provide essential follow-up care to this population. In this article we discuss our institution's experience with rapid implementation of telemedicine in a multi-site neonatal follow-up program as well as benefits and limitations of the use of telemedicine in this context. Finally, we discuss the current problems that must be solved in order to optimize telemedicine as a tool for providing comprehensive, multidisciplinary medical and developmental care to high risk infants and their families.
format Online
Article
Text
id pubmed-8022519
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-80225192021-04-06 Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19 DeMauro, Sara B. Duncan, Andrea F. Hurt, Hallam Semin Perinatol Article Little empirical data support the use of telemedicine to provide medical and developmental follow-up care to preterm and high-risk infants after hospital discharge. Nevertheless, the COVID-19 pandemic temporarily rendered telemedicine the only means by which to provide essential follow-up care to this population. In this article we discuss our institution's experience with rapid implementation of telemedicine in a multi-site neonatal follow-up program as well as benefits and limitations of the use of telemedicine in this context. Finally, we discuss the current problems that must be solved in order to optimize telemedicine as a tool for providing comprehensive, multidisciplinary medical and developmental care to high risk infants and their families. Elsevier Inc. 2021-08 2021-04-06 /pmc/articles/PMC8022519/ /pubmed/33892961 http://dx.doi.org/10.1016/j.semperi.2021.151430 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
DeMauro, Sara B.
Duncan, Andrea F.
Hurt, Hallam
Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19
title Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19
title_full Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19
title_fullStr Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19
title_full_unstemmed Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19
title_short Telemedicine use in neonatal follow-up programs – What can we do and what we can't – Lessons learned from COVID-19
title_sort telemedicine use in neonatal follow-up programs – what can we do and what we can't – lessons learned from covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022519/
https://www.ncbi.nlm.nih.gov/pubmed/33892961
http://dx.doi.org/10.1016/j.semperi.2021.151430
work_keys_str_mv AT demaurosarab telemedicineuseinneonatalfollowupprogramswhatcanwedoandwhatwecantlessonslearnedfromcovid19
AT duncanandreaf telemedicineuseinneonatalfollowupprogramswhatcanwedoandwhatwecantlessonslearnedfromcovid19
AT hurthallam telemedicineuseinneonatalfollowupprogramswhatcanwedoandwhatwecantlessonslearnedfromcovid19

Ejemplares similares